Clinical assessment of tetra-sodium 2-methyl-1: 4-naphthohydroquinone diphosphate as a radiosensitiser in the radiotherapy of malignant tumours.

Source:http://linkedlifedata.com/resource/pubmed/id/13106198

Download in:

View as

General Info

PMID
13106198